Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

714 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Expert consensus on late stage of critical care management].
Tang B, Chen WJ, Jiang LD, Zhu SH, Song B, Chao YG, Song TJ, He W, Liu Y, Zhang HM, Chai WZ, Yin MG, Zhu R, Liu LX, Wu J, Ding X, Shang XL, Duan J, Xu QH, Zhang H, Wang XM, Huang QB, Gong RC, Li ZZ, Lu MS, Wang XT. Tang B, et al. Among authors: liu y, liu lx. Zhonghua Nei Ke Za Zhi. 2023 May 1;62(5):480-493. doi: 10.3760/cma.j.cn112138-20221005-00731. Zhonghua Nei Ke Za Zhi. 2023. PMID: 37096274 Chinese.
[Expert consensus on the application of critical care ultrasonography in invasive procedures].
Zhang Q, Liu LX, Huo Y, Zhang HM, Chao YG, Zeng QB, Si X, Cen ZR, Zhu R, Shang XL, Yin MG, Duan J, Zhang LN, Liu ZY, Zhu Y, He W, Wu J, Cai SH, Chen WJ, Lyu LW, Ren H, Zhang J, Xu QH, Zhu WH, Sun JH, Liu HT, Ai SM, Zhang M, Lu MS, Wang XT. Zhang Q, et al. Among authors: liu lx, liu ht, liu zy. Zhonghua Nei Ke Za Zhi. 2024 May 1;63(5):439-461. doi: 10.3760/cma.j.cn112138-20230828-00092. Zhonghua Nei Ke Za Zhi. 2024. PMID: 38715481 Chinese.
The Aging Biomarker Consortium represents a new era for aging research in China.
Ren J, Song M, Zhang W, Cai JP, Cao F, Cao Z, Chan P, Chen C, Chen G, Chen HZ, Chen J, Chen XC, Ci W, Ding BS, Ding Q, Gao F, Gao S, Han JJ, He QY, Huang K, Ju Z, Kong QP, Li J, Li J, Li J, Li X, Liu B, Liu F, Liu JP, Liu L, Liu Q, Liu Q, Liu X, Liu Y, Luo X, Ma S, Ma X, Mao Z, Nie J, Peng Y, Qu J, Ren R, Song W, Songyang Z, Sun L, Sun YE, Sun Y, Tian M, Tian XL, Tian Y, Wang J, Wang S, Wang S, Wang W, Wang X, Wang X, Wang YJ, Wang Y, Wong CCL, Xiang AP, Xiao Y, Xiao ZX, Xie Z, Xiong W, Xu D, Yang Z, Ye J, Yu W, Yue R, Zhang C, Zhang H, Zhang L, Zhang X, Zhang Y, Zhang YW, Zhang Z, Zhao T, Zhao Y, Zhou Z, Zhu D, Zou W, Pei G, Liu GH. Ren J, et al. Nat Med. 2023 Sep;29(9):2162-2165. doi: 10.1038/s41591-023-02444-y. Nat Med. 2023. PMID: 37468667 No abstract available.
Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study.
Zhang Y, Zhou H, Suo S, Zhuang J, Yang L, He A, Liu Q, Du X, Gao S, Li Y, Li Y, Chen Y, Wu W, Zhu H, He G, Hong M, Jiang Q, Jiang Z, Jing H, Wang J, Xu N, Yue L, Zheng C, Zhou Z, Jin C, Li X, Liu L, Xu Y, Wu D, Zhang F, Zhang J, Wu L, Yin H, Lv B, Xiao Z, Jin J. Zhang Y, et al. Blood Cancer J. 2024 Dec 18;14(1):216. doi: 10.1038/s41408-024-01202-8. Blood Cancer J. 2024. PMID: 39695117 Free PMC article. Clinical Trial.
714 results